SEOUL (Reuters) – South Korea’s food and drug safety ministry has granted final approval for the use of Johnson & Johnson’s coronavirus vaccine as the country pushes ahead with its vaccination campaign, the News1 agency reported on Wednesday.
The decision was made after a panel of South Korean advisers last week recommended that the single-dose shot was safe and effective, the report said.
The J&J vaccine marks the third COVID-19 vaccine to be authorised in South Korea, following ones from AstraZeneca and Pfizer/BioNTech, both of which require two doses.
(Reporting by Sangmi Cha and Hyonhee Shin; Editing by Jacqueline Wong)
